ANA CANTU: Open Payments
NPI 1215430897 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 11 payments from 8 companies in 2025. Trend: 2023 $391 · 2024 $571 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $71 |
| Amgen Inc. | 2 | $35 |
| TerSera Therapeutics LLC | 1 | $28 |
| Lundbeck LLC | 1 | $23 |
| Phadia US Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
Products named: MOUNJARO, OTEZLA, Zoladex, REXULTI, ImmunoCAP, Wegovy, FRUZAQLA, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
